Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
TOP STORIES — Diabetes News and Research
Sleep: Why it’s Crucial for Teens with Diabetes
Fracture Risk and Sodium-Glucose Transport Inhibitors
SGLT Inhibitors as Adjunct Therapy with Insulin
MOST POPULAR ARTICLES OF THE MONTH
#1 Updated Consensus Report on Diabetic Nutrition Therapy
#2 First Major Breakthrough In 20 Years For The Treatment of Diabetic Kidney Disease and Heart Failure
#3 FDA Approves First Oral GLP-1 Treatment for Type 2 Diabetes, But Wait!
Editor's Note
Have you ever heard the phrase “If I only had a dollar for every time….”? There is nowhere that this seems to be the comment more often than when the FDA adds a side effect and later there are enough challenges to get them to change it. My favorite one was the whole debacle with the TZD’s, and our good friend Dr. Steven Nissen.
It looks like history may repeat itself based on an article review by our intern Usif Darwish, PharmD Candidate, Florida A&M University, College of Pharmacy & Pharmaceutical Sciences. It seems that there is a controversy brewing over the SGLT-2 inhibitors and increased fracture risk.
Read our intern’s article and then get ready for the fireworks.
Dave Joffe
Editor-in-chief
TOP STORIES -- Diabetes News and Research
This study covers the implications of sleep and its effect on behavioral and physiological implications in teens with type 1 diabetes.
Did the FDA make a mistake by labeling SGLT2 inhibitors as a fracture risk?
In regards to pharmacotherapy, patients with type 1 diabetes end up solely relying on insulin therapy for their diabetes management: what if there is an add on option?
About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.